Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02848742 · ClinicalTrials.gov registry record · NA

Dermal Cryotherapy for Treatment of Pigmented Lesions

A NA study, sponsored by R2 Dermatology.

Completed
Registry status
NA
Development phase
377
Enrollment target

NCT02848742: Completed NA study, sponsored by R2 Dermatology.

NCT02848742 is a NA study that has completed, run by R2 Dermatology. The registered enrollment target is 377 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02848742, a NA study, has completed, sponsored by R2 Dermatology.

COMPLETED
Registry status
NA
Development phase
377 participants
Enrollment target

Study Summary

Study to evaluate the ability of the Dermal Cooling System to reduce pigmentation in benign pigmented lesions.

Primary Outcome

Changes in pigmentation graded using a 4-point standardized scale

Interventions

  • DEVICE Dermal Cooling System

Trial Details

FieldValue
Enrollment Target 377 participants
Start Date 2016-06
Est. Completion 2020-03
Phase NA
R2 Dermatology

6 total trials

What the finished NCT02848742 record still lists

NCT02848742 is an interventional study that assigns participants to a tested intervention. The registered 377 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 0 conditions, and to 1 intervention - of which Dermal Cooling System is the first listed.

NCT02848742 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02848742 about?

NCT02848742 is a clinical study titled "Dermal Cryotherapy for Treatment of Pigmented Lesions". Study to evaluate the ability of the Dermal Cooling System to reduce pigmentation in benign pigmented lesions.

What is the current status of trial NCT02848742?

This trial is currently completed. It is a NA study. The enrollment target is 377 participants. The study started on 2016-06. Estimated completion is 2020-03.

What interventions are being tested in trial NCT02848742?

The interventions under investigation include: Dermal Cooling System (DEVICE).

Who is sponsoring clinical trial NCT02848742?

This trial is sponsored by R2 Dermatology, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02848742's enrollment target sits among peer trials

377 274th of 2000 higher than 1,727 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07024784 · 377 participants · Phase 2

    A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • NCT04254185 · 378 participants · NA

    Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

  • NCT06616584 · 378 participants · Phase 2

    Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • NCT03102125 · 376 participants · Phase 4

    Allograft Dysfunction in Heart Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02848742, the US trial registry maintained by the National Library of Medicine. NCT02848742 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.